Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions

Genes and Development

Volumn 28, Issue 14, 2014, Pages 1592-1603

  Zheng, Wei ^a,b   Nurmi, Harri ^a,b   Appak, Sila ^c,d   Sabine, Amélie ^e   Bovay, Esther ^e   Korhonen, Emilia A ^b   Orsenigo, Fabrizio ^f,g   Lohela, Marja ^b   D'Amico, Gabriela ^b   Holopainen, Tanja ^b   Leow, Ching Ching ^h   Dejana, Elisabetta ^f,g   Petrova, Tatiana V ^e,i   Augustin, Hellmut G ^c,d   Alitalo, Kari ^a,b  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h MEDIMMUNE   (United States)

ⁱ EPFL   (Switzerland)

Author keywords

Angiopoietin 2; Junction; Lymphatic; VE cadherin

Indexed keywords

ANGIOPOIETIN 2; JUNCTION; LYMPHATIC; VE-CADHERIN;

ANGIOPOIETIN-2; ANIMALS; CADHERINS; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; GENE DELETION; INTERCELLULAR JUNCTIONS; LYMPHANGIOGENESIS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION;

EID: 84904356702     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.237677.114     Document Type: Article

References (45)

1. Alitalo K. 2011. The lymphatic vasculature in disease. Nat Med 17: 1371-1380.
2. Augustin HG, Koh GY, Thurston G, Alitalo K. 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-177.
3. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada M, Molendini C, Dejana E, et al. 2007. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204: 2349-2362.
4. Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, Adams R, Muro AF, Sheppard D, Mäkinen T. 2009. Integrin-α9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17: 175-186.
5. Betsholtz C. 2004. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15: 215-228.
6. Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M. 2008. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46: 74-80.
7. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. 2008. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 335: 17-25.
8. Dellinger M, Hunter R, Bernas M, Gale N, Yancopoulos G, Erickson R, Witte M. 2008. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319: 309-320.
9. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897-1909.
10. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al. 2006. Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
11. Furumoto TA, Miura N, Akasaka T, Mizutani-Koseki Y, Sudo H, Fukuda K, Maekawa M, Yuasa S, Fu Y, Moriya H, et al. 1999. Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development. Dev Biol 210: 15-29.
12. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, et al. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3: 411-423.
13. Gerber HP, Hillan KJ, RyanAM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. 1999. VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159.
14. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998.
15. Holopainen T, López-Alpuche V, Zheng W, Heljasvaara R, Jones D, He Y, Tvorogov D, D'Amico G, Wiener Z, Andersson LC, et al. 2012a. Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. Cancer Res 72: 3512-3521.
16. Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Heloterä H, et al. 2012b. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104: 461-475.
17. Huang H, Bhat A, Woodnutt G, Lappe R. 2010. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 10: 575-585.
18. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. 2011. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121: 2278-2289.
19. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80.
20. Koltowska K, Betterman KL, Harvey NL, Hogan BM. 2013. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development 140: 1857-1870.
21. Lee J, Kim KE, Choi DK, Jang JY, Jung J-J, Kiyonari H, Shioi G, Chang W, Suda T, Mochizuki N, et al. 2013. Angiopoietin-1 guides directional angiogenesis through integrin αvβ5 signaling for recovery of ischemic retinopathy. Sci Transl Med 5: 203ra127.
22. Leow CC, Coffman K, Inigo I, Breen S, Czapiga M, Soukharev S, Gingles N, Peterson N, Fazenbaker C, Woods R, et al. 2012. MEDI3617, a human anti-angiopoietin 2monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models. Int J Oncol 40: 1321-1330.
23. Lobov IB, Brooks PC, Lang RA. 2002. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci 99: 11205-11210.
24. Maisonpierre PC. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
25. Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, Berti A, Politi LS, Gentner B, Brown JL, Naldini L, et al. 2011. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19: 512-526.
26. Norrmén C, Ivanov KI, Cheng J, Zangger N, DelorenziM, JaquetM, Miura N, Puolakkainen P, Horsley V, Hu J, et al. 2009. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 185: 439-457.
27. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, Ristagno G, Maddaluno L, Koh GY, Franco D, et al. 2012. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3: 1208.
28. Patan S. 1998. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 56: 1-21.
29. Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10: 974-981.
30. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA. 2005. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97: 14-21.
31. Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hägerling R, Pollmann C, Bebber D, Pfenniger A, Miura N, Dormond O. 2012. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell 22: 430-445.
32. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
33. Schulte-Merker S, Sabine A, Petrova TV. 2011. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol 193: 607-618.
34. Sun JF, Phung T, Shiojima I, Felske T, Upalakalin JN, Feng D, Kornaga T, Dor T, Dvorak AM, Walsh K. 2005. Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci 102: 128-133.
35. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
36. Tammela T, Alitalo K. 2010. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140: 460-476.
37. van der Heijden M, van Nieuw Amerongen GP, Chedamni S, van Hinsbergh VWM, Johan Groeneveld AB. 2009. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin Ther Targets 13: 39-53.
38. Vestweber D, Winderlich M, Cagna G, Nottebaum AF. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19: 8-15.
39. Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, Vilgrain I, Huber P. 2006. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26: 1067-1077.
40. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769-778.
41. Yang Y, Oliver G. 2014. Development of the mammalian lymphatic vasculature. J Clin Invest 124: 888-897.
42. Yao LC, Baluk P, Srinivasan RS, Oliver G, McDonald DM. 2012. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am J Pathol 180: 2561-2575.
43. ZhengW, Tammela T, Yamamoto M, Anisimov A, Holopainen T, Kaijalainen S, Karpanen T, Lehti K, Yla-Herttuala S, Alitalo K. 2011. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 118: 1154-1162.
44. Zheng W, Aspelund A, Alitalo K. 2014. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 124: 878-887.
45. Ziegler T, Horstkotte J, Schwab C, Pfetsch V, Weinmann K, Dietzel S, Rohwedder I, Hinkel R, Gross L, Lee S, et al. 2013. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 123: 3436-3445.